Thin tubes known as catheters are put into the body during various procedures. Medical add-ons called stabilization devices are used to firmly retain the catheter in place. There are expected to be significant growth opportunities for the catheter stabilization devices market as a result of the growing use of catheter stabilization devices in a variety of end-users, including home care settings, hospitals, ambulatory surgical centers, clinics, diagnostic centers, and others.
New York, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Catheter Stabilization Devices Market Size, Share & Industry Trends Analysis Report By Products, By End User, By Regional Outlook and Forecast, 2022 - 2028" - https://www.reportlinker.com/p06314987/?utm_source=GNW Applications for catheter stabilization devices include cardiovascular treatments, general surgery, respiratory operations, and other procedures. Additionally, it is used as a urinary catheter to empty fluid from abdominal abscesses, to administer medication, during angioplasty and angiography, and to test blood pressure in veins and arteries. The urinary catheter is designed to securely hold the catheter because of how it is made. Urine backflow is prevented using urinary catheter devices. It aids in reducing urethral injury risk. It is brought by the catheter moving or becoming loose. The market is anticipated to be driven by factors including rising demand for minimally invasive procedures, increased prevalence of lifestyle illnesses like malignancies, cardiovascular diseases, and renal failure, as well as an increase in the number of operations that may necessitate these gadgets for postoperative care. The aging of the population also leads to a greater requirement for these gadgets. All across the world, intravascular catheter use is a crucial component of contemporary healthcare. With an increase in utilization, these have developed into a necessary component in hospitals and clinics. Hospitals and clinics buy more than 150 million of these devices annually for the delivery of drugs, IV fluids, parenteral nutrition, and hemodynamic status monitoring. Additionally, it predicts the annual placement of more than 5 million central intravascular catheters. It is becoming more common to have urinary diseases such as cystitis, urine retention, urinary incontinence, benign prostate hyperplasia, kidney stones, and other conditions that cause bladder dysfunction. COVID-19 Impact Analysis COVID-19 has been classified as an emergency health crisis by the World Health Organization (WHO). The pandemic problem had had a significant influence on the healthcare sector. One of the most crucial steps in treating COVID-19 patients was intubation. The demand for ventilators, intubation equipment, and ventilation stabilization tools such as catheter stabilization devices had increased due to the rise of Corona patients. Patients with COVID 19 received IVIG (Intravenous Immunoglobin) as a supportive treatment. It contributes to the rise in demand for catheter stabilizing technology to reduce the dangers of catheter movement. The COVID-19 pandemic is anticipated to have a short-term detrimental effect on the expansion of the catheter business because of the on-hold services, such as therapeutic, diagnostic, and surgical services. Market Growth Factors Rising Rates Of Lifestyle Diseases Globally, lifestyle disorders including obesity and CVD are on the rise. Since 1975, the global rate of obesity has more than tripled. Since 1975, the global obesity rate has more than tripled. In every region of the world except some areas of sub-Saharan Africa and Asia, there are more obese individuals than underweight people. According to research, the prevalence of CVD has nearly tripled in China and India during the past ten years. As a result, the market for securement devices is expanding globally due to the increase in cardiac procedures. Growing Numbers Of People Are Getting Older The rising elderly population is one of the biggest issues facing emerging nations. The incidence of chronic illnesses in the elderly, such as peripheral arterial disease, heart disease, and venous thromboembolism, is also anticipated to drive growth in the catheter market. By 2020, more than 19.1% of persons aged 55 to 65 worldwide would have peripheral vascular disease, with nearly 27% of men and more than 21% of women affected, as per a study by the Centers for Disease Control and Prevention. The aged population, which is expanding at an extraordinary speed in the Asia Pacific region, is the largest in the world. Market Restraining Factors Increased Likelihood Of Urinary Tract Infections Urinary tract infection is the most frequent side effect in patients using IC. However, the frequency of UTIs connected to IC varies significantly in published literature. This may depend on the evaluation techniques used, such as the patient population under study, the IC procedures, the frequency of the urine measurements, the UTI criteria, etc. Becka and Volset3 examined traits that potentially foretell the emergence of bacteriuria and clinical UTI in 302 individuals using Clean IC (CIC). Low age, neurogenic bladder disorder, and non-self-catheterization, as well as urine leaking in patients with the neurogenic disorder, were predictive variables of clinical UTI in women, while low age, neurogenic bladder dysfunction, and high mean catheterization volume were predictive variables in men. Product Outlook By product, the catheter stabilization devices market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices, Peripheral Securement Devices, Urinary Catheter Securement Devices, Chest Drainage Tube Securement Devices, and Others. The central venous catheter securement devices segment witnessed a significant revenue share in the catheter stabilization devices market in 2021. Due to advantages including fewer repeat surgeries and reinsertions, fewer disruptions during treatments, and lower CVC replacement costs, CVC securement is becoming more and more important. End-Use Outlook Based on end-use, the catheter stabilization devices market is classified into Hospitals, Home Care Settings, and Others. The hospitals segment procured the largest revenue share in the catheter stabilization devices market in 2021. It is because a lot of surgeries are carried out in hospitals. In hospitals, catheters are frequently utilized for a variety of therapies. In hospitalized patients, the prevalence of illnesses linked to their use is significant. Regional Outlook Region-wise, the catheter stabilization devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region garnered the highest revenue share in the catheter stabilization devices market in 2021. Due to the rise in catheter implantation, the United States has the greatest market here and globally. The Joint Commission estimates that almost 3 million of the estimated 300 million catheters used in the United States each year are central venous catheters. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Cardinal Health, Inc., Merit Medical Systems, Inc., ICU Medical, Inc., TIDI Products, LLC, ConvaTec Group PLC, and Medline Industries, Inc. (Centurion Medical Products Corporation). Scope of the Study Market Segments covered in the Report: By Products • Arterial Securement Devices • Central Venous Catheter Securement Devices • Peripheral Securement Devices • Urinary Catheter Securement Devices • Chest Drainage Tube Securement Devices • Others By End User • Hospitals • Homecare Settings • Others By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • 3M Company • Becton, Dickinson and Company • Baxter International, Inc. • B. Braun Melsungen AG • Cardinal Health, Inc. • Merit Medical Systems, Inc. • ICU Medical, Inc. • TIDI Products, LLC • ConvaTec Group PLC • Medline Industries, Inc. (Centurion Medical Products Corporation) Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06314987/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Huobi Global, one of the world's leading digital asset exchanges, today announced a special user promotion to celebrate the upcoming Ethereum merge, which is estimated to take place in mid-Septembe...
Business owners of companies that deliver packages for FedEx Ground are set to voice their concerns at a Las Vegas expo.
The Food and Drug Administration authorized Novavax Inc.'s COVID-19 vaccine for use in U.S. teenagers on Friday. Novavax's recombinant protein-based vaccine uses different technology than the mRNA shots developed by Moderna Inc. and BioNTech SE , and received an emergency-use authorization by the FDA for adults in July. The vaccine still requires a policy recommendation for use by the Centers for Disease Control, which followed the FDA by about a week when authorizing the Novavax shot for adults
Prices at the pump have fallen again, but the summer decline is mostly over, according to industry watchers.
The Food and Drug Administration approved a new depression pill from Axsome Therapeutics on Friday, and AXSM stock catapulted higher.
President Joe Biden signed the wide-ranging Inflation Reduction Act (IRA) into law on Tuesday afternoon, bringing welcome news for many retirees.
Oil companies are minting money, and as long as crude prices don’t fall too much further, the rally should continue.
The drug, which can take effect within a week, uses a different mechanism than traditional treatments for depression.
Nearly 1 in 3 Americans haven’t been to the dentist since before the COVID-19 pandemic began. Why?
Nancy Davis said that when she learned this month that the fetus she was carrying had a rare and fatal condition, she and her partner were devastated. “There’s nothing I wanted more than this child,” she said. As they weighed their options, she said, her doctor referred her to an abortion clinic. Yet what ensued in the days after she made that wrenching decision to have an abortion shows how the U.S. Supreme Court’s ruling overturning the constitutional right to abortion has sown confusion and t
U.S. based monkeypox vaccine manufacturer targets December for first batch of doses for delivery.
©Starz! Movie Channel/Courtesy Everett CollectionOne of the stars of the drama Spartacus has died aged 49 after announcing in January that he had cancer. Ioane ‘John’ King was diagnosed with adenocarcinoma cancer which quickly spread to his pancreas and other organs. The New Zealand actor played gladiator Rhaskos in the Starz franchise Spartacus. Manu Bennett, who played Crixus in the show, paid tribute to his co-star on Instagram. “On Spartacus John was hired as an extra but with a powerful pre
Story at a glance As of 2017, approximately 5.4 million U.S. adults have autism spectrum disorder. Results of the large study may help drive future treatments for the condition. Researchers also hope findings will spur genetic testing to identify those at risk. An analysis of over 150,000 people, 20,000 of whom have autism, revealed over…
Bavarian Nordic, which has a large stockpile of bulk vaccine material, will have a Michigan company fill vials, addressing a manufacturing bottleneck.
Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has gotten FDA clearance.
NBC News Chief Foreign Correspondent Richard Engel announced Thursday that his son Henry, 6, has died. “Our beloved son Henry passed away.
Rivian is discontinuing the cheapest trim level of its all-electric truck and SUV known as the Explore package due to low demand, according to emails sent this week to customers. The company said in the email, which was first cited in the Rivian Owners Forum, that customers with a pre-order for the Explore package will need to reconfigure to the Adventure trim by September 1 or have their preorder cancelled. Rivian also issued information on its customer support page that explains why it cancelled the package and what customers' options are.
Dr. Ilona Butova almost looks out of place in her neatly pressed lavender scrubs as she walks through a door frame that hangs from a crumbled wall into what used to be an administrative office of her hospital in Zolochiv. Since Russia's invasion on Feb. 24, space to treat patients at the hospital has shrunk constantly because of damage. Care is being provided in the hardest-hit areas by doctors who have refused to evacuate or have rushed in as volunteers, putting themselves at great risk.
The $18 billion market for colon-cancer screening perfectly illustrates the difference between innovation and hype. It has implications for Exact Sciences , Guardant Health and others setting their sights on the market. A number of Wall Street analysts say that liquid biopsies can claim a significant share of the colon-cancer-screening market.
Story at a glance A woman from Texas who spent over a year in a hospital with COVID-19 has been discharged. Jazmin Kirkland, 34, first became infected in August of 2021. The ordeal highlights the toll COVID-19 can take on healthy, young individuals. Relaxed COVID-19 guidelines issued by the Centers for Disease Control and Prevention…